Chairman Jiang Yu sold a total of 887, ( 378,474 + 333,069 + 176,457 ) shares over three separate transactions between December 24 and 29, reducing his holdings by approximately 9.1% from late November levels. Following these dispositions, his ownership stands at roughly 9.1 million shares, down from about 10 million earlier in the quarter. The sales were disclosed via SEC filings on December 24, 26 and 29, underscoring a sustained wave of insider profit-taking from the boardroom.

NNE shares are down nearly 20% year-to-date, trading below both their 50-day and 200-day moving averages of roughly mid-30s. The beta of 7.17 highlights extreme sensitivity to broader market swings. Market capitalization remains around $1.2 billion, while the trailing P/E ratio stands at –23.09, reflecting continued pre-profit development and capital intensity. The stock’s 52-week range stretches from $17.26 at the low end to $60.87 at its peak, illustrating the pronounced up-and-down price dynamics.

Among seven analysts covering NNE, one holds a strong-buy view, four maintain buy ratings, one has a hold recommendation and one advises sell. Consensus earnings forecasts call for a full-year loss of approximately $0.92 per share, an improvement from last year’s $1.10 estimated deficit. Recent quarterly results delivered a loss of $0.19 per share, beating the consensus by $0.14 and signaling incremental technical progress despite the pre-revenue status.

Recent 3Q filings reveal new stakes from Archer Investment Corp, Tripletail Wealth Management and Caitong International Asset Management, each acquiring positions valued between $39,000 and $48,000. US Bancorp DE also increased its holding by over 50%, buying an additional 400 shares. On the strategic front, NNE signed a memorandum of understanding with the University of Illinois Urbana-Champaign to develop and operate its first KRONOS microreactor on campus, securing a high-profile validation site that could serve as a commercial reference for future deployments.